These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20423344)

  • 21. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
    Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
    Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the differences between ouabain and digitalis glycosides.
    Fuerstenwerth H
    Am J Ther; 2014; 21(1):35-42. PubMed ID: 21642827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for an intracellular site of action in the heart for two hydrophobic cardiac steroids.
    Núñez-Durán H; Fernández P
    Life Sci; 2004 Jan; 74(11):1337-44. PubMed ID: 14706565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ischemia/reperfusion-induced alterations of enzymatic and signaling functions of the rat cardiac Na+/K+-ATPase: protection by ouabain preconditioning.
    Belliard A; Gulati GK; Duan Q; Alves R; Brewer S; Madan N; Sottejeau Y; Wang X; Kalisz J; Pierre SV
    Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27702882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of cardiac actions of ouabain and its binding to Na+, K+-adenosine triphosphatase by increased sodium influx in isolated guinea-pig heart.
    Temma K; Akera T
    J Pharmacol Exp Ther; 1982 Nov; 223(2):490-6. PubMed ID: 6290640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ouabain-digoxin antagonism in rat arteries and neurones.
    Song H; Karashima E; Hamlyn JM; Blaustein MP
    J Physiol; 2014 Mar; 592(5):941-69. PubMed ID: 24344167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why Whip the Starving Horse When There Are Oats for the Starving Myocardium?
    Fürstenwerth H
    Am J Ther; 2016; 23(5):e1182-7. PubMed ID: 25259953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of direct renal arterial infusion of bufalin and ouabain in conscious sheep.
    Yates NA; McDougall JG
    Br J Pharmacol; 1993 Mar; 108(3):627-30. PubMed ID: 8385530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Cardiotoxicity of Low Doses of Digoxin, Ouabain, and Oleandrin.
    Botelho AFM; Miranda ALS; Freitas TG; Milani PF; Barreto T; Cruz JS; Melo MM
    Cardiovasc Toxicol; 2020 Dec; 20(6):539-547. PubMed ID: 32488807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structures and characterization of digoxin- and bufalin-bound Na+,K+-ATPase compared with the ouabain-bound complex.
    Laursen M; Gregersen JL; Yatime L; Nissen P; Fedosova NU
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1755-60. PubMed ID: 25624492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cardiac glycosides on excitation-contraction coupling in frog skeletal muscle fibres.
    Sárközi S; Szentesi P; Jona I; Csernoch L
    J Physiol; 1996 Sep; 495 ( Pt 3)(Pt 3):611-26. PubMed ID: 8887770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744).
    Micheletti R; Mattera GG; Rocchetti M; Schiavone A; Loi MF; Zaza A; Gagnol RJ; De Munari S; Melloni P; Carminati P; Bianchi G; Ferrari P
    J Pharmacol Exp Ther; 2002 Nov; 303(2):592-600. PubMed ID: 12388640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketanserin inhibits digoxin-induced arrhythmias in the anaesthetized guinea-pig.
    Kalyoncu NI; Ozyavuz R
    Fundam Clin Pharmacol; 1999; 13(6):646-9. PubMed ID: 10626751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological profile of the new inotropic agent AT-11.
    Lee AS; Wu TS; Su MJ
    Eur J Pharmacol; 2008 Feb; 580(1-2):224-30. PubMed ID: 18031738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides.
    Gao J; Wymore RS; Wang Y; Gaudette GR; Krukenkamp IB; Cohen IS; Mathias RT
    J Gen Physiol; 2002 Apr; 119(4):297-312. PubMed ID: 11929882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of alpha-adrenoceptor agonists and antagonists on ouabain-induced arrhythmias and cardiac arrest in guinea-pig.
    Thomas GP; Tripathi RM
    Br J Pharmacol; 1986 Oct; 89(2):385-8. PubMed ID: 2877699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitory action of peruvoside and neriifolin on Na+, K(+)-ATPase].
    Ye YX; Yang XR
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):491-4. PubMed ID: 1966653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of positive inotropic and toxic effects of cardiac glycosides by amiloride.
    Kennedy RH; Akera T; Brody TM
    Eur J Pharmacol; 1985 Sep; 115(2-3):199-210. PubMed ID: 2998821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
    Schoner W; Scheiner-Bobis G
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular magnesium and cardiotonic steroid toxicity in isolated myocardial preparations.
    Kafiluddi R; Kennedy RH; Seifen E
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1120-7. PubMed ID: 2532249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.